Cardiovascular imaging research at the crossroads.

Area of Science:

• Cardiology
• Medical Imaging
• Health Policy

Background:

• Cardiovascular (CV) imaging is crucial for therapeutic decision-making in millions of patients annually.
• The increasing use of CV imaging has led to escalating costs and concerns about its overall value and quality.
• Current healthcare systems often prioritize volume over demonstrated quality and guideline-adherent practices.

Purpose of the Study:

• To review the current health policy landscape of CV imaging.
• To explore the future of CV imaging research, focusing on comparative effectiveness.
• To evaluate how imaging markers link to outcomes to establish test value.

Main Methods:

• Review of current health policy and reimbursement models for CV imaging.
• Analysis of the relationship between imaging markers and patient outcomes.
• Discussion of the paradigm shift towards comparative effectiveness research in CV imaging.

Main Results:

• CV imaging's high utilization and costs ($80 billion annually) are not always matched by demonstrable quality or improved outcomes.
• A lack of clear links between imaging markers and outcomes challenges the value proposition of many CV imaging tests.
• The current system incentivizes high volume and extensive justification for procedures, often exceeding best practices.

Conclusions:

• Establishing the value of CV imaging requires demonstrating an inextricable link between imaging markers and health outcomes.
• Future evaluation of CV imaging technologies by payers and agencies will rely on this value benchmark.
• High-quality comparative effectiveness research is essential to guide the future of CV imaging and ensure it improves patient health outcomes.